DCLK1 and schizophrenia: Our data suggests some bias for TSSIII usage in schizophrenia, producing both D02 (full length DCLK1) and D04 (N-terminal DCL-like region) variants, which have been shown to prevent apoptosis in neuroblastoma cells [65].